Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults with Attention-Deficit/Hyperactivity Disorder: with a Secondary Examination of Impact of Treatment on Family Functioning
Atomoxetine
B4Z-US-LYCW
NCT00190775
Attention Deficit Hyperactivity Disorder
Phase 4
 
November 2015

Powered by ideaPoint, Inc.